|
MrWhy.com » Videos » Amgen Sees Fractional Gains After Failure of Cancer Drug Stu |
|
|
Amgen Sees Fractional Gains After Failure of Cancer Drug Stu
|
Amgen Sees Fractional Gains After Failure of Cancer Drug Stu
Amgen Inc. (AMGN) opened higher and is holding fractional gain in early trader after announcing that a potential cancer treatment it’s developing with Takeda Pharmaceutical Company Ltd. failed to meet its key goal in a study. The drug, motesanib, was tested on lung cancer patients in a late-stage study, but failed to improve overall survival rates for patients with non-squamous non-small cell lung cancer.
Video Length: 0
Date Found: March 30, 2011
Date Produced: March 30, 2011
View Count: 0
|
|
|
|
|
I got punched by an old guy, for farting near his wife. Read MoreComic book creator Stan Lee talks the future of the medium in the digital age. Panelists Zachary... Read MoreThe U.S. launch of Spotify is still on music lovers' minds. Join Zachary Levi, from NBC’s... Read MoreTuesday: Rupert Murdoch testifies before Parliament on the hacking scandal that brought down "News... Read MoreAfter a long slump, the home construction industry may be showing signs of life. But as Bill... Read More | 1 2 3 4 5 |
|
|
|